Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J W Adamson

Showing results (141-150 of 193) with videos related to

Pageof 20
Sort By:
Gene|September 30, 1994
Alternatively spliced mRNAs encoding soluble isoforms of the erythropoietin receptor in murine cell lines and bone marrowC Barron, A R Migliaccio, G Migliaccio, et al.
The Journal of Laboratory and Clinical Medicine|June 1, 1985
Erythropoietin kinetics in normal and uremic sheepJ Mladenovic, J W Eschbach, J R Koup, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1990
Muramyl dipeptide induces production of hemopoietic growth factors in vivo by a mechanism independent of tumor necrosis factorV C Broudy, K Kaushansky, S G Shoemaker, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1989
Effect of red cell hypertransfusion on thrombocytopoietic regeneration following irradiation and bone marrow transplantation in the mouseC Chatelain, S A Burstein, S K Erb, et al.
Progress in Clinical and Biological Research|January 1, 1989
Selection of lineage-restricted cell lines immortalized at different stages of hematopoietic differentiation from the murine cell line 32 DG Migliaccio, A R Migliaccio, V Broudy, et al.
Kidney International|May 1, 1988
The anemia of end-stage renal disease: hematopoietic progenitor cell responseG M Segal, J W Eschbach, J C Egrie, et al.
Contributions to Nephrology|January 1, 1989
USA multicenter clinical trial with recombinant human erythropoietin (Amgen). Results in hemodialysis patientsJ W Eschbach, M R Downing, J C Egrie, et al.
The New England Journal of Medicine|January 8, 1987
Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trialJ W Eschbach, J C Egrie, M R Downing, et al.
Journal of Cellular Physiology|October 1, 1993
Induction of the murine "W phenotype" in long-term cultures of human cord blood cells by c-kit antisense oligomersA R Migliaccio, G Migliaccio, G Mancini, et al.
The American Journal of Medicine|April 1, 1978
Tetralogy of Fallot with hypoxemia in a patient with beta thalassemia intermediaD T Peterson, R M Winslow, J W Adamson, et al.
Pageof 20

Showing results (141-150 of 193) with videos related to

Sort By:
Pageof 20
Gene|September 30, 1994
Alternatively spliced mRNAs encoding soluble isoforms of the erythropoietin receptor in murine cell lines and bone marrowC Barron, A R Migliaccio, G Migliaccio, et al.
The Journal of Laboratory and Clinical Medicine|June 1, 1985
Erythropoietin kinetics in normal and uremic sheepJ Mladenovic, J W Eschbach, J R Koup, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1990
Muramyl dipeptide induces production of hemopoietic growth factors in vivo by a mechanism independent of tumor necrosis factorV C Broudy, K Kaushansky, S G Shoemaker, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1989
Effect of red cell hypertransfusion on thrombocytopoietic regeneration following irradiation and bone marrow transplantation in the mouseC Chatelain, S A Burstein, S K Erb, et al.
Progress in Clinical and Biological Research|January 1, 1989
Selection of lineage-restricted cell lines immortalized at different stages of hematopoietic differentiation from the murine cell line 32 DG Migliaccio, A R Migliaccio, V Broudy, et al.
Kidney International|May 1, 1988
The anemia of end-stage renal disease: hematopoietic progenitor cell responseG M Segal, J W Eschbach, J C Egrie, et al.
Contributions to Nephrology|January 1, 1989
USA multicenter clinical trial with recombinant human erythropoietin (Amgen). Results in hemodialysis patientsJ W Eschbach, M R Downing, J C Egrie, et al.
The New England Journal of Medicine|January 8, 1987
Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trialJ W Eschbach, J C Egrie, M R Downing, et al.
Journal of Cellular Physiology|October 1, 1993
Induction of the murine "W phenotype" in long-term cultures of human cord blood cells by c-kit antisense oligomersA R Migliaccio, G Migliaccio, G Mancini, et al.
The American Journal of Medicine|April 1, 1978
Tetralogy of Fallot with hypoxemia in a patient with beta thalassemia intermediaD T Peterson, R M Winslow, J W Adamson, et al.
Pageof 20